Stay updated on Avapritinib vs Regorafenib in GIST Clinical Trial
Sign up to get notified when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.

Latest updates to the Avapritinib vs Regorafenib in GIST Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This appears to be an internal versioning change and does not alter study data or user-facing content.SummaryDifference0.0%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2 on the page.SummaryDifference0.0%

- Check37 days agoChange DetectedNo additions or deletions were detected on the page; the study details and related sections appear unchanged.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision: v3.4.2 has replaced v3.4.1 on the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check59 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this is a minor page/version change that does not modify the study content.SummaryDifference0.0%

- Check74 days agoChange DetectedAdded Show glossary and Hide glossary options, and updated labels such as 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

Stay in the know with updates to Avapritinib vs Regorafenib in GIST Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avapritinib vs Regorafenib in GIST Clinical Trial page.